Alzheimer Disease
Disease State Hub
Featured
05/25/2023
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
05/25/2023
05/24/2023
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide a preview of their session, "Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem ” at our Practical Updates...
05/24/2023
05/15/2023
Following two 12-week studies, the FDA has approved the first ever medication for treating agitation in patients with dementia due to Alzheimer disease.
05/15/2023
Interactive Features
05/03/2023
Increasing age is a risk factor for Alzheimer dementia (AD), and as the US population grows older and lives longer, new and existing cases of AD are projected to rise as well. How many older Americans are...
05/03/2023
02/21/2023
Your patient is a 46-year-old woman with a family history of dementia and obesity. Based on her family history, she asks you if there is a way to reduce her risk of developing dementia, and a way to stay...
02/21/2023
01/13/2023
The US FDA recently approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion with...
01/13/2023
mild cognitive impairment
mild cognitive impairment
01/13/2023
Statin use has been controversial. Do they cause or protect against cognitive impairment? Tell us your thoughts via this poll.
01/13/2023
10/14/2022
How much do you know about Alzheimer disease? Take this short quiz based on statistics from the Alzheimer's Association to find out.
10/14/2022
Clinical Insights
05/25/2023
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
05/25/2023
05/24/2023
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C provide a preview of their session, "Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem ” at our Practical Updates...
05/24/2023
01/13/2023
In this video, Madhav Thambisetty, MD, discusses a new treatment for patients with Alzheimer disease, lecanemab, recently approved by the FDA, including the presumed mechanism of action, benefits, risks,...
01/13/2023
05/19/2022
In this podcast, Thomas Holland, MD, from Rush University, answers our questions about his team's latest research on the effect of flavonols on the risk for Alzheimer dementia, as well as his other research...
05/19/2022
05/03/2022
New research investigated the nervous system cell types in which putative migraine-associated genes are expressed. Lead author William Renthal, MD, PhD, answers our questions about this research.
05/03/2022
